What’s on: AIDS 2020 Virtual for treatment activists
NewsKicking off on Monday 6 July, with a workshop on innovative strategies to reduce prohibitive drug prices, we’ve compiled some...
Read more about What’s on: AIDS 2020 Virtual for treatment activists
-
Ukraine: 100% LIFE opposes patent on TB drug for children
NewsOur campaign partner in Ukraine, 100% LIFE, has submitted the first patent opposition on bedaquiline in the Eastern Europe and Central...
Read more about Ukraine: 100% LIFE opposes patent on TB drug for children
-
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Call to action NewsOur partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....
Read more about Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
-
COVID-19: Local manufacturing essential if we are to “treat all”
NewsITPC led a virtual roundtable last week (26 May 2020) attended by civil society treatment experts, researchers, and national pharmaceutical...
Read more about COVID-19: Local manufacturing essential if we are to “treat all”
-
Moroccan civil society calls for compulsory licence on Gilead’s possible COVID-19 drug
NewsOn 12 May 2020, Gilead Sciences announced voluntary licenses to five generic manufacturers in India and Pakistan allowing them to...
-
Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
NewsBedaquiline (BDQ) is a core component of an ‘all-oral’ solution to multi-drug resistant TB (MDR-TB), and is recommended by the...
Read more about Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
-
Civil society asks WHO and Unitaid to ensure equitable access to COVID-19 technologies – and that commitment is binding
Call to action NewsIn an open letter, sent to Unitaid, the World Health Organization (WHO) and its Member States today, 86 civil society...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
Call to action NewsAbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
-
COVID-19 pandemic: ‘An opportunity of a lifetime’?
News Research The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...
Read more about COVID-19 pandemic: ‘An opportunity of a lifetime’?
-
Global headlines: Potential COVID-19 drugs are over-priced
News ResearchFrom the front page of Le Monde, to the Financial Times, Bloomberg, Al Jazeera and others, research demonstrating that potential...
Read more about Global headlines: Potential COVID-19 drugs are over-priced
